This is a synthetic peptide designed for use in combination with anti-MAP3K14 Antibody(ARP42161_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
浓度
1 mg/mL
缓冲液
Final peptide concentration is 1 mg/mL in PBS.
注意事项
Avoid repeated freeze-thaw cycles.
储存条件
-20 °C
储存方法
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
抗原
MAP3K14
(Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14))
背景
This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor.
Alias Symbols: FTDCR1B, HS, HSNIK, NIK
Protein Interaction Partner: CHUK,IKBKAP,IKBKB,TRAF1,TRAF2,TRAF3,TRAF5,TRAF6,ALPL,CASP8,CDC37,CHUK,EDAR,EGFR,FBL,GRB10,GRB14,GRB7,HSP90AA1,HSP90AB1,IKBKAP,IKBKB,IKBKG,MAP2K4,MAP3K14,MAP3K7,MAP3K8,MAPK3,NFKB2,PEBP1,PELI3,RIPK1,RPL30,RPL4,RPL5,RPL6,RPS11,RPS13,TRAF1,TRAF2,TRAF3,TRAF5,T